By Karen Deyo, Director of Investor Research, Israel BD, LSN
Life Science Nation’s (LSN) virtual events continue to be successful with a global gathering of early-stage startups, as well as the investors and strategic partners looking to invest in them. With attendees representing over 30 countries from 5 continents participating in this week’s Redefining Early Stage Investment (RESI), more than 1500 meetings were booked over the three days of the conference. Individual companies booked up to 40 meetings over the course of the conference, with more than 75% of meetings booked occurring between companies and investors.
In addition to an extremely active partnering platform, the panels, workshops and pitch sessions were well-attended and dynamic, with enthusiastic audience participation. RESI events continue to show that even in an all virtual platform, the needle keeps moving forward in the life sciences, bringing life-saving technologies closer and closer to market.
Next Phase Newsletter 
Leave a Reply